BLFSNCMHealthcare·Medical Instruments & Supplies#30 in industry

BioLife Solutions, Inc.

Reports in 10d· 2026-05-07

-14.3% · 90d

$21.41

+0.03 (+0.14%)

After-Hours $21.41(+0.00)

News

No News Yet

Press releases and SEC filings for BLFS will appear here as they are published.

Check back later for updates

Key Data

Market Cap$1.03B

Open$21.30

Prev Close$21.38

Day Range$21.24 – $22.05

52W Range$17.86 – $29.62

Volume220,195

P/E (TTM)—

EPS$-0.25

Dividend Yield—

Beta2.00

Profit Margin-4.78%

Revenue Growth63.90%

Price Target$32.40(+51.3%)

Next Earnings2026-05-07(10d)

Analyst Ratings

Strong Buy10 analysts

Buy 10Hold 0Sell 0

About

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction products, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; CryoCase cryo-compatible transparent rigid containers for closed-system fill and retrieval, and automated cell processing machines; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

Healthcare · Medical Instruments & Supplies

155 employees

www.biolifesolutions.com